Skip to content

Public FDA record

Z-1586-2015: BARD MAX-CORE Disposable Core Biopsy Instrument Gauge x Length 18g x 20cm The BARD MAX-CORE Disposable

Recall record Z-1586-2015 for Bard Peripheral Vascular Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1586-2015
Company in FDA record
Bard Peripheral Vascular Inc
FDA classification date
May 6, 2015
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The firm is recalling Bard MAX-CORE Disposable Core Biopsy Instrument due to the risk of having self-activation-related issues.

Source facts

Action
Bard sent an Urgent Medical Device Recall Notification letter dated April 9, 2015 to their customers. The firm's letter provided customers with the following instructions: -Do not use or further distribute any affected product. -Check all inventory locations within the institution for Bard Max-Core Disposable Core Biopsy Instruments for the recalled product code/lot number combination. -If further distributed any of the product code/lot numbers listed, please immediately contact that location, advise them of the recall and have them return the affected product to BVD address listed. -Remove any identified product from the shelves. -If used the affected product, complete, and return the attached Recall and Effectiveness Check Form indicating no product will be returned. Report any new and/or previously unreported adverse events associated with this recall to the US Food and Drug Administration's ("FDA") MedWatch Program by phone at 1-800-FDA-1088; by fax at 1-800- FDA-0178; by mail to MedWatch. Food and Drug Administration. 5600 Fishers Lane. Rockville. MD 20857- 9787: or on line at http://wwvdda.gov/medwatch/report.htm. Once the product affected by this recall has been removed from inventory: -Fill out the Recall and Effectiveness Check Form. Be sure to state the quantities and lot numbers of each recalled product that are in stock. -Call the firm's Recall Coordinator Regan Gealy at 1-770-784-6471 or email at Regan.Gealy@crbard.com. The Recall Coordinator will issue either a Return Authorization (RCL) Number or Consignment Recall Number (CRC) to facilitate the expedient return of the product. -Fax the Recall and Effectiveness Check Form back to at 1-770-784-6469. -BPV will provide replacement product for the returned product. A mailing label is going to be enclosed to return the affected product. Mark the outside package as "RECALLED PRODUCT" and include the RCL or CRC number. All products should be returned to the follo
Initiated
2015-04-09
Root cause
Process design
Terminated
2015-09-25
Distribution
Worldwide Distribution - US Nationwide in the states of: AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NH, NJ, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WI, WV and the countries of: France, Mexico, Netherlands, Panama, United Kingdom, Switzerland, Spain, Poland, Norway, Iceland, Italy, Greece, Finland, Belgium, Germany, Austria, China, Taiwan, Singapore, Korea, Australia, and Japan.
Recall number
Z-1586-2015
Recall status
Terminated
CDRH record ID
135737
FDA classified
2015-05-06
Recall event number
70952

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗